Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial.
Michael J KovacsPhilip S WellsDavid R AndersonAlejandro Lazo-LangnerClive KearonShannon M BatesMark BlosteinSusan R KahnSam SchulmanElham SabriSusan SolymossTim RamsayErik YeoMarc A Rodgernull nullPublished in: BMJ (Clinical research ed.) (2021)
Clinicaltrials.gov NCT00432796.